Accession ID: MIRT004074 [miRNA, hsa-miR-373 :: CNOT6, target gene]
pre-miRNA Information
pre-miRNA ID hsa-mir-373 LinkOut: [miRBase ]
Synonyms MIRN373, hsa-mir-373, miRNA373, MIR373
Description Homo sapiens miR-373 stem-loop
2nd Structure of pre-miRNA
Mature miRNA Information
Mature miRNA hsa-miR-373-3p
Mature Sequence 44| GAAGUGCUUCGAUUUUGGGGUGU |66
Evidence Experimental
Experiments Cloned
Putative hsa-miR-373-3p Targets LinkOut: [ TargetScanS 5.1 | MicroCosm | microRNA.org | miRecords | miRDB | miRo | miRNAMap 2.0 ]
Mature miRNA hsa-miR-373-5p
Mature Sequence 6| ACUCAAAAUGGGGGCGCUUUCC |27
Evidence Experimental
Experiments Cloned
Putative hsa-miR-373-5p Targets LinkOut: [ TargetScanS 5.1 | MicroCosm | microRNA.org | miRecords | miRDB | miRo | miRNAMap 2.0 ]
miRNA-target interaction network
Gene Information
Gene Symbol CNOT6 LinkOut: [ Entrez Gene | BioGPS | Wikipedia | iHop ]
Synonyms CCR4, KIAA1194
Description CCR4-NOT transcription complex, subunit 6
Transcript NM_015455   LinkOut: [ RefSeq ]
Expression LinkOut: [ BioGPS ]
KEGG Pathway hsa03018    RNA degradation - Homo sapiens (human)
Putative miRNA Targets on CNOT6 LinkOut: [ TargetScan 5.1 | MicroCosm | miRNAMap 2.0 ]
3'UTR of CNOT6
(miRNA target sites are highlighted)
>CNOT6|NM_015455|3'UTR
   1 TAGTCAAGCACCTTCAGAGGACAGCCTTGATTCACTTGTAAACTTGTGAAAATCTGAACATAGGGGAGTGAGGTATGGCC
  81 ACTGAGGATTTTTGCTTGCTTAAGAATGATTTGGACTTTCAATCTGATTATTTGATAAGGATATAGTATGAAAGCCAGGT
 161 GCTAGCAACAGACAAATTCTGAGCCCAATATGCTTTATACTGCTAGACAGGGATTGGTGTGTTTGCACCTGTCTTTCATT
 241 TGTCATAAGAGATTTTCCTATTTCTTCTACCCAATAGAATATTTTCATGCCTGGAAATAGGAAAATGTGTGAACAGCGTA
 321 TTCTCTTCACACAGAAATCTGTAGCACTGCTTTTTTGAGGCCAGTAGCAACATCCAGAGATCATTCTTCCATACTTTACT
 401 CCCTCCTTTTTCAGACTTGTTTGTAAAGTACAGAATCTGAATTTAGCCTTTATGATTGTATATGATCCACAGAAGACCTG
 481 ATTTATGAAATTTTGTACTAAAATCATTTGGAAATGATTGTATTGTAAACTGAGGCTAAATTTTTTTTTAAACCTGTTTC
 561 ATGTGTTATAAAGGCCAGCTTGTAAAAGAAGCTGCAACAGACTTTCTCTGCTCATGATTTGCACTCTTAGGGTTTTGTTA
 641 GCCCTTTTGTACTACTTTCTTTTTAAATTGAGAACATGGTTCTTTACATATAAATCTGCTTCAACCTTAGGATGTTTTCA
 721 GACCAGAGGCAACTTATTCATGAATTTTTATGAAAACTATCTACTAGGACAGATAAGCTGAACAGTGATGATCTGTAGAC
 801 ATTTATGGACTGAATGTAATGGTTGATATATGTACATTCTGATATTTTTAAATCTTTAACTTTTTAAAGTTAAAAACCTA
 881 CAGCTGCTTAGGTCCAGCTTCTTAACTCTTTTTGAGACACTTCCTGTCCTATCTCCACTGTGCCTGCCTAAATTTGTTCT
 961 CACCAAGCACTGCCTGTGCATGCAGAGAAAATCTGTGCATCCTCTTTTATATTTTTAAAATACTGTTTAACATTTGTGAG
1041 AATTTTATGAAAATGCTTTTGTATGAGCTGTGGCTTTTTCCCATTGTGAAGCATTGAATATCACATTTTGGAACATGTTA
1121 TAGGGTGAGTCCCTGGATCTTTGCTCACCAGATCCAAGCACTGCTTCTCGGTGTCATTGCAGTGTGCTGCTTGTCACCCA
1201 GAATACTACTATCATGTGAATTCTTTTTGTCGTCAGTGTCTTTTCCTTAGTCTTTTTGTTGTTGTTGTTGTTGTTGTTTT
1281 AATCATTCCTTTTTTAAGAAGAAGTAATTTTCCATTTATGAAGCAGTATGAATTAGATGTATTTTCAAAACAGGTCCCTA
1361 AGACAATTCTTCAGATCATTTTTAAAATGACTAAGTCATTTTAGTATGTCAAGCAAGATAAAAATTACATCATACCGTCT
1441 ATTTTGCCCATAGTGCCATTTAGAGATGAAAACCAGCTTTAACTTTGCAAAGTGAACATGTACATGGTCTGCTCTCATTT
1521 ATTCATTCTTCTCTCAAAAGTCAAATGAATGCAGAGGGAGCTTGGTCAAACTGCTTTTGTTTCAACTGCAGGCAGGGGAG
1601 CAAAAGGACGCCATGTGAGCATTAGGAAAAAAAATACTCACTCTTACTAACAATTTTTATACAGAAAATGAGTCATTTTG
1681 GAAATGATTCTTATGTTTTTTTTTTTTCTCCTTTTAGAAAATTCTCCAAAAGGTTTTGATGTTGAATCTTGGTCTTGGAC
1761 CTGTTTTTTCCTTTGAGGGTTTTTTGTTTTTTGTTTTTTCTAGGATTTCATTGTGATGTTTTGGTTTTGTTTTTTGCTTT
1841 TTGTTTAAGTTGTGCTGACACCAAACACATCCAGTTTATAATCAGTACATTGGAAAGCTGGTATTGATGTAGAACCAGTG
1921 CATAACTTTTTATGGGGTTTTGTTATTGGTTTTTTTTTGTAAAGTGTGAATAAAAGGTATGTTTACTCATTTTTCCTGAA
2001 CACTGTGTTGGTAATGTGCATCATGACAATTTCCAGTGAAGGTGAGCTGGAGCTGGTTGGACTAATGAGACTGAGGAAGC
2081 AGCTTTTCCTACGATCTGCATTATGTAATCACAGGTCCAGAGAGCTTTATGGAAGCGGGAGAGGAGGAGCACTTACTCAT
2161 GTTGTATTTGTTAATGGAGGATGTCATCTTTTCATAGATGCTGGAACTAGAGTGCACTTGTTAGATGCTAAAGGTTTGAG
2241 CTTTACACAAAATGTCTTCATCTGTATTTGTTATTGTCTACAATATATTTGAATTTGGGGCAGCATATTAAGATGTAATG
2321 GCCTGTTATGTCTTGAAAATACTTGTTTTGCCTCTTCCAGGCATACTGCATTCTGTGGATCAGTTTGAACAGCTTCTCCA
2401 CCTTATTTGGACAGTGATAAATTGAACCAAGAGTGTAGATTTACAAGTGTAACCTTCAAAAGAGGAAGAACTATTTGGGG
2481 TCTGTAGGTAATGAACAGTCACACCAAAATAGACTATGATGCTTTTGTTAAGAAAGGTTTCATGTTTTAGATATTTTCCG
2561 TGTCCTAAATAATTTTCAATAATCTATAATCCCTAAAATGCAATAAAAACTAGTATGTTTTCACGGTGTATATTTTTTTT
2641 CAAAAATTCTGTAACAAATATATTTAATGTGTTGCCATAATGTCATTTCAGTATTTTTGCTGGATAAATCCATTTTAGAA
2721 ATGTCTTACAAAAAGTTTAGGGCATGTTTTCTGTTTTAAAGACCAGAAGTTTGAAGGCACCCAAATCCTTGTCGCCAATC
2801 TCCTGAAGTACAGCTTTACCATATTAGTGGTCATTATTTATGCTTTGAGAGTTTCAATATTGTTCGTCAAGTTAACTTAT
2881 GGCATAATTTAAGCTAAAGTTGTAGAAATGAATTGTTGAGTGCAACTTTCATAGTCCCAAAGATAGGCAGAGAACATCTC
2961 CAGAAATGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTTTAATATGATTTAGTGACAACCAGGAAAACTTACTTGGGAT
3041 TATTAGCACTTTCAAACTTAGGGACATTATTAAATTGGATGGAATGCACTTCTAAATGTTTAAATTAAAATTTCAAAGCT
3121 CTTTCGAGATTCAGGTTCTCAATAATAATATTCAAGTTTTAGAGTTTCACTTTGTACTATTTAAATTTATGGAACTAGTT
3201 TCCATACTGACTTGTAAGGTTTTGGGGTCATATATAAGGACTAAAGCCAAGCTAGGCAAAACAATGACAGCACCGTTTTT
3281 TCAGTGAAGCTCTCAGAATGTCCAGTACAGATGTTGCAGATAATTCCAAGAACTCCTTCAGCAGGTGTTCTTCACCATTC
3361 GTAAACAGTATTTTAAGATGTTCACTTTGCTCTTCTTTTTGGTTACATACATTTTAATAACTGGTATGTTGAAGTAGTGT
3441 CTAAAAGTATCTAGTCTTTATTCACAGTACATTATATTGTGTGATGCACTGGACTAACTCTTGTTTACCATTCATGTAAC
3521 AAAACCCAGCACATTATCTGCACTATAAGCTCAAAGAATGTCACATCCGCCCAGACAGCTCTTTGATGAGGGTGATGGGA
3601 ACTGAATAAACCATACGGACTGGCAGTAACAAGGGCTTTTACTGTTCTGTTCAGTGGAACCTTCTTGGTCAAATTGTAAT
3681 TAGCTAGCATTATATTTATATACAGGGTCTTTTTTCTTTACCGATGTATTTTCCTACTCATAGCCAACCAATAAATTCAG
3761 TATCTGTTTCAAATATTTTAGAAGTGTAGTTTGTATAGCTGTAGTACTGAGGTTTGAGGAAAAATAAATGTTGATCAGCA
3841 GACCACGTATTTAAAATTCTGAATCTTCTGGGACAGGGTTGTAACTCAGCCTTCCAAAGGGAAGAGTGCAGGGGGACGGG
3921 GCCATGATATGGGGAAATGGTGTAAACTAATGTATTTCTTTATTGGCTGTTATTCTGTATAACACTCATATCTTTGCCAA
4001 AGTTCAATTTTATATTTAGGCAACTGATGGTCCTTTTGCATTTAGGATTTTCGTTGTTGTTACCTTATACCTCATGATAT
4081 AAGGAATGGGCTCATGTGTCTTCCGTCTTTTGGAAGGAGGTTGACATATTTTAAATAAATGCTTTTAAATACAGTAAA
Target sites Provided by authors  Predicted by miRanda
miRNA-target interactions (Predicted by miRanda)
IDDuplex structurePositionScoreMFE
1
miRNA  3' uguggggUUUUAGCUUCGUGAAg 5'
                 |:|:  |:||||||| 
Target 5' aagcgggAGAGGAGGAGCACTTa 3'
2133 - 2155 152.00 -13.80
2
miRNA  3' ugUGGGGUUUUAG-CUUCGUGAag 5'
            || | :||||| | ||||||  
Target 5' tcACACAGAAATCTGTAGCACTgc 3'
327 - 350 149.00 -15.40
3
miRNA  3' ugUGGG-GUUUUAGCUUCGUGAag 5'
            :|:| | |:||| |||||||  
Target 5' ttGCTCACCAGATCCAAGCACTgc 3'
1141 - 1164 149.00 -16.10
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target hsa-miR-373 :: CNOT6    [ Functional MTI ]
Validation Method Microarray
Conditions HeLa
Location of target site 3'UTR
Original Description (Extracted from the article) ... Filtering the expression profiles for genes characterized by the LocusLink database12 that were significantly downregulated (P < 0.001) at both 12 and 24 h, gave sets of 96 and 174 annotated genes downregulated by miR-1 and miR-124, respectively (Supplementary Tables 1 and 2).//{These MTI shown in Supplementary Table 1,2,4} ...

- Lim, L. P. Lau, N. C. Garrett-Engele, P. et al., 2005, Nature.

Article - Lim, L. P. Lau, N. C. Garrett-Engele, P. et al.
- Nature, 2005
MicroRNAs (miRNAs) are a class of noncoding RNAs that post-transcriptionally regulate gene expression in plants and animals. To investigate the influence of miRNAs on transcript levels, we transfected miRNAs into human cells and used microarrays to examine changes in the messenger RNA profile. Here we show that delivering miR-124 causes the expression profile to shift towards that of brain, the organ in which miR-124 is preferentially expressed, whereas delivering miR-1 shifts the profile towards that of muscle, where miR-1 is preferentially expressed. In each case, about 100 messages were downregulated after 12 h. The 3' untranslated regions of these messages had a significant propensity to pair to the 5' region of the miRNA, as expected if many of these messages are the direct targets of the miRNAs. Our results suggest that metazoan miRNAs can reduce the levels of many of their target transcripts, not just the amount of protein deriving from these transcripts. Moreover, miR-1 and miR-124, and presumably other tissue-specific miRNAs, seem to downregulate a far greater number of targets than previously appreciated, thereby helping to define tissue-specific gene expression in humans.
LinkOut: [PMID: 15685193]